Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
Securing Growth and Robust Leadership in American Aviation Act, H.R. 3935, issues related to transportation of organs
Federal Aviation Administration Reauthorization Act of 2023, S.1939, issues related to transportation of organs
Saving Organs One Flight at a Time Act, H.R.4362 (generally, no specific provisions)
Duration: February 22, 2021
to
present
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations , Medical/Disease Research/Clinical Labs
Spending: about $1,330,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Food & Drug Administration (FDA), Transportation - Dept of (DOT), Federal Aviation Administration (FAA), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on April 17.
Original Filing: 301552422.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
Securing Growth and Robust Leadership in American Aviation Act, H.R. 3935, issues related to transportation of organs
Federal Aviation Administration Reauthorization Act of 2023, S.1939, issues related to transportation of organs
Saving Organs One Flight at a Time Act, H.R.4362 (generally, no specific provisions)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA)
4th Quarter, 2023
In Q4, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301536594.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
U.S. Organ Procurement and Transplantation Act, H.R.2544/S.1668 (generally, no specific provisions)
FY2024 Transportation, Housing and Urban Development, and Related Agencies Appropriation bill, H.R.4820, issues related to drone transportation of organs meant for transplantation
FY2024 Labor, Health and Human Services, Education, and Related Agencies Appropriation bill, issues related to Organ Procurement Organizations certification and mergers
Securing Growth and Robust Leadership in American Aviation Act, H.R. 3935, issues related to transportation of organs
Federal Aviation Administration Reauthorization Act of 2023, S.1939, issues related to transportation of organs
Saving Organs One Flight at a Time Act, H.R.4362 (generally, no specific provisions)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Transportation - Dept of (DOT) Federal Aviation Administration (FAA)
3rd Quarter, 2023
In Q3, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301516412.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
U.S. Organ Procurement and Transplantation Act, H.R.2544/S.1668 (generally, no specific provisions)
FY2024 Transportation, Housing and Urban Development, and Related Agencies Appropriation bill, H.R.4820, issues related to drone transportation of organs meant for transplantation
FY2024 Labor, Health and Human Services, Education, and Related Agencies Appropriation bill, issues related to Organ Procurement Organizations certification and mergers
Securing Growth and Robust Leadership in American Aviation Act, H.R. 3935, issues related to transportation of organs
Federal Aviation Administration Reauthorization Act of 2023, S.1939, issues related to transportation of organs
Charlotte Woodward Organ Transplant Discrimination Act, H.R. 2706/S.1183 (generally, no specific provisions)
Saving Organs One Flight at a Time Act, H.R.4362 (generally, no specific provisions)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Transportation - Dept of (DOT) Federal Aviation Administration (FAA)
2nd Quarter, 2023
In Q2, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301488443.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Transportation - Dept of (DOT) Federal Aviation Administration (FAA)
1st Quarter, 2023
In Q1, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on April 20, 2023.
Original Filing: 301463666.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to payment policies for organ donation and transplantation (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Transportation - Dept of (DOT) Federal Aviation Administration (FAA)
4th Quarter, 2022
In Q4, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Jan. 11, 2023.
Original Filing: 301426135.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Issues related to organ donation and transplantation in the Consolidated Appropriations Act, 2023, H.R. 2617
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Transportation - Dept of (DOT) Federal Aviation Administration (FAA)
3rd Quarter, 2022
In Q3, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Oct. 13, 2022.
Original Filing: 301403570.xml
Lobbying Issues
Issues related to recommendations in the National Academies of Sciences, Engineering, and Medicine report entitled "Realizing the Promise of Equity in the Organ Transplantation System" (generally, no specific legislation)
Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA) Centers For Medicare and Medicaid Services (CMS) Health Resources & Services Administration (HRSA) Executive Office of the President (EOP)
2nd Quarter, 2022
In Q2, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301390499.xml
Lobbying Issues
FY 2023 Labor, HHS, Education and Related Agencies Appropriations Act, provisions supporting the work of the Department of Health and Human Services to implement the Kidney Collaborative and recommendations from the National Academy of Sciences to increase the number of organ transplants to 50,000 per year by 2026 (bill number not yet available)
FY 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, provisions related to shortages of organ preservation solution (bill number not yet available)
Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Issues related to promoting improvements in the donation, transport, transplantation and survivability of organs (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
1st Quarter, 2022
In Q1, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301368929.xml
Lobbying Issues
Issues related to increasing organ transplantation to 50,000 per year (generally, no specific legislation)
Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Food and Drug Administration FY2023 Appropriations Act (Agriculture, Rural Development, FDA and Related Agencies Appropriations), provisions relating to encouraging the FDA to continue to address the shortage of organ preservation solution and to report on the status of preservation solution supply (bill number not yet available)
FY 2023 Labor, HHS, Education and Related Agencies Appropriations Act, provisions supporting the work of the Department of Health and Human Services to implement the Kidney Collaborative and recommendations from the National Academy of Sciences to increase the number of organ transplants to 50,000 per year by 2026 (bill number not yet available)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
4th Quarter, 2021
In Q4, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301336010.xml
Lobbying Issues
H.R. 3893, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021 (generally, no specific provisions)
H.R. 4356, Food and Drug Administration FY2022 Appropriations Act (Agriculture, Rural Development, FDA and Related Agencies Appropriations), provisions relating to encouraging the FDA to maintain its expertise in perfusion technologies and prioritize review of applications for such technologies
Issues related to increasing organ transplantation to 50,000 per year (generally, no specific legislation)
Issues related to addressing the shortage of crucial preservation solutions for safe organ transplantation (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
Issues related to urging Congress to oppose Centers for Medicare & Medicaid Services proposed rule to alter organ transplantation reimbursement policies in the 2022 Medicare Inpatient Prospective Payment System (generally, no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on Oct. 20, 2021.
Original Filing: 301313252.xml
Lobbying Issues
Federal regulations and legislative issues related to organ donation and transplantation and other policy efforts to improve organ donation (no specific legislation or regulations).
H.R. 3893, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021 (generally, no specific provisions).
Issues related to expanding the Administrations Kidney Transplant collaborative to include other organs (generally, no specific language or regulations).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
H.R. 4502, FY 2022 Labor, Health and Human Services, Education, and Related Agencies Funding Bill, provisions related to organ donation and transplantation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on July 20, 2021.
Original Filing: 301288670.xml
Lobbying Issues
Federal regulations and legislative issues related to organ donation and transplantation, and other policy efforts to improve organ donation (no specific legislation or regulation); FY 2022 House and Senate Appropriations Bills (bill numbers not yet available).
Issues related to expanding the Administrations Kidney Transplant collaborative to include other organs (generally, no specific legislation or regulations).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
Federal regulations and legislative issues related to organ donation and transplantation, and other policy efforts to improve organ donation (no specific legislation or regulation); FY 2022 House and Senate Appropriations Bills (bill numbers not yet available).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Budget/Appropriations
1st Quarter, 2021
In Q1, ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS had in-house lobbyists. The report was filed on April 19, 2021.
Original Filing: 301259092.xml
Lobbying Issues
Federal regulations and legislative issues related to organ donation and transplantation, including Centers for Medicare and Medicaid Services regulations on Organ Procurement Organizations Conditions for Coverage; FY 2022 House and Senate Appropriations Bills (bill numbers not yet available); and other policy efforts to improve organ donation (no specific legislation or regulations).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Office of Management & Budget (OMB)
Type of Issue
Health Issues Medicare/Medicaid Budget/Appropriations
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate